TSH-secreting pituitary adenoma: benefits of pre-operative octreotide

Endocrinology, Diabetes & Metabolism Case Reports

article

I R Wallace¹  E Healy²  R S Cooke³  P K Ellis⁴  R Harper⁵  S J Hunter¹ 

[1] Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital;Department of Neuropathology, Royal Victoria Hospital;Department of Neurosurgery, Royal Victoria Hospital;Department of Radiology, Royal Victoria Hospital;Department of Endocrinology and Diabetes, Ulster Hospital

关键词: Adult;    Female;    White;    United Kingdom;    Pituitary;    Pituitary;    TSH;    Pituitary adenoma;    Inappropriate TSH secretion;    Palpitations;    Anxiety;    Heat intolerance;    Sleep disturbance;    Tremulousness;    Thyroid function;    TSH;    FT4;    FT3;    Ultrasound scan;    FSH;    TRH stimulation;    Octreotide suppression test;    MRI;    Triiodothyronine (T3) suppression;    Transsphenoidal surgery;    Octreotide;    Somatostatin analogues;    Novel treatment;    June;    2015;   

DOI  :  10.1530/EDM-15-0007

学科分类：血液学

来源: Bioscientifica Ltd.

【 摘 要 】

TSH-secreting pituitary adenomas are rare and the optimal investigation and management is uncertain. We describe a case ofa 43 year-old woman with a TSH-secreting pituitary adenoma, highlighting diagnostic testing and our use, pre-operativelyof somatostatin analogue therapy, which induced biochemical euthyroidism and a reduction in tumour size.

【 授权许可】

CC BY-NC-ND